These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1030 related articles for article (PubMed ID: 33971111)

  • 1. SARS-CoV-2 Infection Is Associated with Reduced Krüppel-like Factor 2 in Human Lung Autopsy.
    Wu D; Lee TH; Huang RT; D Guzy R; Schoettler N; Adegunsoye A; Mueller J; Husain A; I Sperling A; Mutlu GM; Fang Y
    Am J Respir Cell Mol Biol; 2021 Aug; 65(2):222-226. PubMed ID: 33971111
    [No Abstract]   [Full Text] [Related]  

  • 2. Increased Expression of ATP12A in Small Airway Epithelia of Post-COVID-19 Pulmonary Fibrosis.
    Abdelgied M; Zhou S; Uhl K; Jager T; Lawson C; Chesla D; Murphy E; Li K; Girgis RE; Li X
    Am J Respir Cell Mol Biol; 2024 Jun; 70(6):527-530. PubMed ID: 38819123
    [No Abstract]   [Full Text] [Related]  

  • 3. SARS-CoV-2 infection of primary human lung epithelium for COVID-19 modeling and drug discovery.
    Mulay A; Konda B; Garcia G; Yao C; Beil S; Villalba JM; Koziol C; Sen C; Purkayastha A; Kolls JK; Pociask DA; Pessina P; de Aja JS; Garcia-de-Alba C; Kim CF; Gomperts B; Arumugaswami V; Stripp BR
    Cell Rep; 2021 May; 35(5):109055. PubMed ID: 33905739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2-induced lung pathology: AHR as a candidate therapeutic target.
    Giovannoni F; Quintana FJ
    Cell Res; 2021 Jan; 31(1):1-2. PubMed ID: 33262451
    [No Abstract]   [Full Text] [Related]  

  • 5. Lung Epithelium Releases Growth Differentiation Factor 15 in Response to Pathogen-mediated Injury.
    Shah FA; Bahudhanapati H; Jiang M; Tabary M; van der Geest R; Tolman NJ; Kochin M; Xiong Z; Al-Yousif N; Sayed K; Benos PV; Raffensperger K; Evankovich J; Neal MD; Snyder ME; Eickelberg O; Ray P; Dela Cruz C; Bon J; McVerry BJ; Straub AC; Jurczak MJ; Suber TL; Zhang Y; Chen K; Kitsios GD; Lee JS; Alder JK; Bain WG
    Am J Respir Cell Mol Biol; 2024 May; 70(5):379-391. PubMed ID: 38301257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial thrombomodulin downregulation caused by hypoxia contributes to severe infiltration and coagulopathy in COVID-19 patient lungs.
    Won T; Wood MK; Hughes DM; Talor MV; Ma Z; Schneider J; Skinner JT; Asady B; Goerlich E; Halushka MK; Hays AG; Kim DH; Parikh CR; Rosenberg AZ; Coppens I; Johns RA; Gilotra NA; Hooper JE; Pekosz A; Čiháková D
    EBioMedicine; 2022 Jan; 75():103812. PubMed ID: 35033854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TMPRSS2 activity may mediate sex differences in COVID-19 severity.
    Okwan-Duodu D; Lim EC; You S; Engman DM
    Signal Transduct Target Ther; 2021 Mar; 6(1):100. PubMed ID: 33649313
    [No Abstract]   [Full Text] [Related]  

  • 8. Illuminating COVID-19 lung disease through autopsy studies.
    Meyerholz DK; McCray PB
    EBioMedicine; 2020 Jul; 57():102865. PubMed ID: 32629393
    [No Abstract]   [Full Text] [Related]  

  • 9. Meta-analysis of Transcriptomic Data from Lung Autopsy and Cellular Models of SARS-CoV-2 Infection.
    Cadore NA; Lord VO; Recamonde-Mendoza M; Kowalski TW; Vianna FSL
    Biochem Genet; 2024 Apr; 62(2):892-914. PubMed ID: 37486510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intersubject Variation in ACE2 Protein Expression in Human Airway Epithelia and Its Relationship to Severe Acute Respiratory Syndrome Coronavirus 2.
    Li K; Wohlford-Lenane C; Bartlett JA; McCray PB
    J Infect Dis; 2021 Oct; 224(8):1357-1361. PubMed ID: 34289058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abrupt Deterioration of COVID-19 Patients and Spreading of SARS COV-2 Virions in the Lungs.
    Filipovic N; Saveljic I; Hamada K; Tsuda A
    Ann Biomed Eng; 2020 Dec; 48(12):2705-2706. PubMed ID: 33140243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative proteomics of hamster lung tissues infected with SARS-CoV-2 reveal host factors having implication in the disease pathogenesis and severity.
    Suresh V; Mohanty V; Avula K; Ghosh A; Singh B; Reddy RK; Parida D; Suryawanshi AR; Raghav SK; Chattopadhyay S; Prasad P; Swain RK; Dash R; Parida A; Syed GH; Senapati S
    FASEB J; 2021 Jul; 35(7):e21713. PubMed ID: 34105201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ORAI1 Limits SARS-CoV-2 Infection by Regulating Tonic Type I IFN Signaling.
    Wu B; Ramaiah A; Garcia G; Hasiakos S; Arumugaswami V; Srikanth S
    J Immunol; 2022 Jan; 208(1):74-84. PubMed ID: 34819389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of meplazumab in healthy volunteers and COVID-19 patients: a randomized phase 1 and an exploratory phase 2 trial.
    Bian H; Zheng ZH; Wei D; Wen A; Zhang Z; Lian JQ; Kang WZ; Hao CQ; Wang J; Xie RH; Dong K; Xia JL; Miao JL; Kang W; Li G; Zhang D; Zhang M; Sun XX; Ding L; Zhang K; Jia J; Ding J; Li Z; Jia Y; Liu LN; Zhang Z; Gao ZW; Du H; Yao N; Wang Q; Wang K; Geng JJ; Wang B; Guo T; Chen R; Zhu YM; Wang LJ; He Q; Yao RR; Shi Y; Yang XM; Zhou JS; Ma YN; Wang YT; Liang X; Huo F; Wang Z; Zhang Y; Yang X; Zhang Y; Gao LH; Wang L; Chen XC; Tang H; Liu SS; Wang QY; Chen ZN; Zhu P
    Signal Transduct Target Ther; 2021 May; 6(1):194. PubMed ID: 34001849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2-mediated dysregulation of metabolism and autophagy uncovers host-targeting antivirals.
    Gassen NC; Papies J; Bajaj T; Emanuel J; Dethloff F; Chua RL; Trimpert J; Heinemann N; Niemeyer C; Weege F; Hönzke K; Aschman T; Heinz DE; Weckmann K; Ebert T; Zellner A; Lennarz M; Wyler E; Schroeder S; Richter A; Niemeyer D; Hoffmann K; Meyer TF; Heppner FL; Corman VM; Landthaler M; Hocke AC; Morkel M; Osterrieder N; Conrad C; Eils R; Radbruch H; Giavalisco P; Drosten C; Müller MA
    Nat Commun; 2021 Jun; 12(1):3818. PubMed ID: 34155207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lung Epithelial Cell Transcriptional Regulation as a Factor in COVID-19-associated Coagulopathies.
    FitzGerald ES; Chen Y; Fitzgerald KA; Jamieson AM
    Am J Respir Cell Mol Biol; 2021 Jun; 64(6):687-697. PubMed ID: 33740387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2 Spike Protein Destabilizes Microvascular Homeostasis.
    Panigrahi S; Goswami T; Ferrari B; Antonelli CJ; Bazdar DA; Gilmore H; Freeman ML; Lederman MM; Sieg SF
    Microbiol Spectr; 2021 Dec; 9(3):e0073521. PubMed ID: 34935423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycated ACE2 receptor in diabetes: open door for SARS-COV-2 entry in cardiomyocyte.
    D'Onofrio N; Scisciola L; Sardu C; Trotta MC; De Feo M; Maiello C; Mascolo P; De Micco F; Turriziani F; Municinò E; Monetti P; Lombardi A; Napolitano MG; Marino FZ; Ronchi A; Grimaldi V; Hermenean A; Rizzo MR; Barbieri M; Franco R; Campobasso CP; Napoli C; Municinò M; Paolisso G; Balestrieri ML; Marfella R
    Cardiovasc Diabetol; 2021 May; 20(1):99. PubMed ID: 33962629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential Effect of SARS-CoV-2 Spike Glycoprotein 1 on Human Bronchial and Alveolar Lung Mucosa Models: Implications for Pathogenicity.
    Rahman M; Irmler M; Keshavan S; Introna M; Beckers J; Palmberg L; Johanson G; Ganguly K; Upadhyay S
    Viruses; 2021 Dec; 13(12):. PubMed ID: 34960806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 infection induces the dedifferentiation of multiciliated cells and impairs mucociliary clearance.
    Robinot R; Hubert M; de Melo GD; Lazarini F; Bruel T; Smith N; Levallois S; Larrous F; Fernandes J; Gellenoncourt S; Rigaud S; Gorgette O; Thouvenot C; Trébeau C; Mallet A; Duménil G; Gobaa S; Etournay R; Lledo PM; Lecuit M; Bourhy H; Duffy D; Michel V; Schwartz O; Chakrabarti LA
    Nat Commun; 2021 Jul; 12(1):4354. PubMed ID: 34272374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 52.